Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Capital Leases: 2020-2021

  • GeneDx Holdings' Capital Leases fell 11.31% to $18.4 million in Q4 2021 from the same period last year, while for Dec 2021 it was $18.4 million, marking a year-over-year decrease of 11.31%. This contributed to the annual value of $18.4 million for FY2021, which is 11.31% down from last year.
  • According to the latest figures from Q4 2021, GeneDx Holdings' Capital Leases is $18.4 million, which was down 11.31% from $20.8 million recorded in Q4 2020.
  • GeneDx Holdings' 5-year Capital Leases high stood at $20.8 million for Q4 2020, and its period low was $18.4 million during Q4 2021.
  • For the 2-year period, GeneDx Holdings' Capital Leases averaged around $19.6 million, with its median value being $19.6 million (2020).
  • Data for GeneDx Holdings' Capital Leases shows a maximum YoY decreased of 11.31% (in 2021) over the last 5 years.
  • Over the past 2 years, GeneDx Holdings' Capital Leases (Quarterly) stood at $20.8 million in 2020, then declined by 11.31% to $18.4 million in 2021.